Gabriele Greve - Search Results

Year	Number of Results
2011	1
2013	1
2015	2
2016	1
2017	2
2018	2
2019	4
2020	3
2021	4
2022	1
2023	2
2024	0

1

Innovative strategies for adverse karyotype acute myeloid leukemia.

Blum S, Greve G, Lübbert M. Blum S, et al. Among authors: greve g. Curr Opin Hematol. 2017 Mar;24(2):89-98. doi: 10.1097/MOH.0000000000000318. Curr Opin Hematol. 2017. PMID: 28099271 Review.

2

In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts.

Greve G, Andrieux G, Schlosser P, Blagitko-Dorfs N, Rehman UU, Ma T, Pfeifer D, Heil G, Neubauer A, Krauter J, Heuser M, Salih HR, Döhner K, Döhner H, Hackanson B, Boerries M, Lübbert M. Greve G, et al. Leukemia. 2023 May;37(5):1018-1027. doi: 10.1038/s41375-023-01876-2. Epub 2023 Apr 6. Leukemia. 2023. PMID: 37024521 Free PMC article.

3

Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives.

Schiffmann I, Greve G, Jung M, Lübbert M. Schiffmann I, et al. Among authors: greve g. Epigenetics. 2016 Dec;11(12):858-870. doi: 10.1080/15592294.2016.1237345. Epub 2016 Nov 15. Epigenetics. 2016. PMID: 27846368 Free PMC article. Review.

4

Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies.

Stomper J, Rotondo JC, Greve G, Lübbert M. Stomper J, et al. Among authors: greve g. Leukemia. 2021 Jul;35(7):1873-1889. doi: 10.1038/s41375-021-01218-0. Epub 2021 May 6. Leukemia. 2021. PMID: 33958699 Free PMC article. Review.

5

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR⁺ Acute Lymphoblastic Leukemia.

Mostufi-Zadeh-Haghighi G, Veratti P, Zodel K, Greve G, Waterhouse M, Zeiser R, Cleary ML, Lübbert M, Duque-Afonso J. Mostufi-Zadeh-Haghighi G, et al. Among authors: greve g. Cancers (Basel). 2023 Aug 30;15(17):4328. doi: 10.3390/cancers15174328. Cancers (Basel). 2023. PMID: 37686604 Free PMC article.

6

The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.

Meier R, Greve G, Zimmer D, Bresser H, Berberich B, Langova R, Stomper J, Rubarth A, Feuerbach L, Lipka DB, Hey J, Grüning B, Brors B, Duyster J, Plass C, Becker H, Lübbert M. Meier R, et al. Among authors: greve g. Blood Cancer J. 2022 Aug 22;12(8):122. doi: 10.1038/s41408-022-00715-4. Blood Cancer J. 2022. PMID: 35995769 Free PMC article. Clinical Trial.

7

Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients.

Stomper J, Meier R, Ma T, Pfeifer D, Ihorst G, Blagitko-Dorfs N, Greve G, Zimmer D, Platzbecker U, Hagemeijer A, Schmitt-Graeff I, Lübbert M. Stomper J, et al. Among authors: greve g. Clin Epigenetics. 2021 Apr 12;13(1):77. doi: 10.1186/s13148-021-01052-2. Clin Epigenetics. 2021. PMID: 33845873 Free PMC article.

8

Decitabine Induces Gene Derepression on Monosomic Chromosomes: In Vitro and In Vivo Effects in Adverse-Risk Cytogenetics AML.

Greve G, Schüler J, Grüning BA, Berberich B, Stomper J, Zimmer D, Gutenkunst L, Bönisch U, Meier R, Blagitko-Dorfs N, Grishina O, Pfeifer D, Weichenhan D, Plass C, Lübbert M. Greve G, et al. Cancer Res. 2021 Feb 15;81(4):834-846. doi: 10.1158/0008-5472.CAN-20-1430. Epub 2020 Nov 17. Cancer Res. 2021. PMID: 33203699

9

Nitroreductase-Mediated Release of Inhibitors of Lysine-Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells.

Herrlinger EM, Hau M, Redhaber DM, Greve G, Willmann D, Steimle S, Müller M, Lübbert M, Miething CC, Schüle R, Jung M. Herrlinger EM, et al. Among authors: greve g. Chembiochem. 2020 Aug 17;21(16):2329-2347. doi: 10.1002/cbic.202000138. Epub 2020 Apr 27. Chembiochem. 2020. PMID: 32227662 Free PMC article.

10

LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML.

Barth J, Abou-El-Ardat K, Dalic D, Kurrle N, Maier AM, Mohr S, Schütte J, Vassen L, Greve G, Schulz-Fincke J, Schmitt M, Tosic M, Metzger E, Bug G, Khandanpour C, Wagner SA, Lübbert M, Jung M, Serve H, Schüle R, Berg T. Barth J, et al. Among authors: greve g. Leukemia. 2019 Jun;33(6):1411-1426. doi: 10.1038/s41375-018-0375-7. Epub 2019 Jan 24. Leukemia. 2019. PMID: 30679800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year